Boston Scientific Launches $1.2 Billion Restructuring Program, Targeting $750 Million in Annual Savings

Medical device company Boston Scientific is launching a global restructuring program that will invest up to $800 million (approximately 1.2 trillion won) through 2029. The plan focuses on optimizing the supply chain and reorganizing the company’s structure. Although workforce reductions are expected, the savings will be reinvested in growth initiatives. Through the restructuring, Boston Scientific plans to achieve approximately $500 million (approximately 750 billion won) in annual pretax cost savings.